Skip to main content Accessibility help
Hostname: page-component-888d5979f-jgqf9 Total loading time: 0.798 Render date: 2021-10-25T12:01:12.244Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Ch. 14 - Filling Complications

Published online by Cambridge University Press:  26 February 2010

Neil S. Sadick
Cornell University, New York
Get access



Slowing down the inevitable course of skin aging has been a popular notion for hundreds of years. Ancient Egyptians compounded early chemical peels using the lactic acid in milk and performed an early form of microdermabrasion with salt, alabaster, and animal oils. More sophisticated methods including soft tissue augmentation with autologous fat were first reported in the German literature by Neuber in 1893.

The first U.S. Food and Drug Administration (FDA)–approved filler was bovine collagen (Zyderm I) in 1981. Since then, a myriad of soft tissue fillers have been introduced. These include both bovine and human collagens (Zyderm, Zyplast, CosmoDerm, and CosmoPlast), hyaluronic acids (Restylane, Perlane, Juvederm, and Hylaform), calcium hydroxyapatite (Radiesse), poly-l-lactic acid (Sculptra), and synthetic polymers such as liquid silicone and Artecoll or Artefill. These procedures have gained popularity as they are generally safe in experienced hands, and many show rapid improvement yielding high levels of clinical satisfaction.

All cosmetic procedures have associated risks. As the incidence of soft tissue augmentation has increased, as would be expected, adverse effects have been reported more commonly. In a survey of 286 patients, McCraken et al. recently reported a 5 percent complication rate among ophthalmologists performing soft tissue augmentation procedures. This article will emphasize the prevention, identification, and treatment complications with a focus on temporary fillers. Permanent fillers (such as Artecoll) permit greater longevity with which comes the greater risk of adverse sequelae. These permanent substances present a greater risk of causing late-onset (>one year) granulomas.

Augmentation Fillers , pp. 129 - 136
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)


Monheit, GD, Chastain, MA. Chemical and mechanical skin resurfacing. In: Bolognia, JL, Jorizzo, JL, Rapini, RP, eds. Dermatology, 1st edn. Elsevier Saunders: Philadelphia, 2003; 2379–2381.Google Scholar
Klein, AW. Techniques for soft tissue augmentation: an “a to z”. Am J Clin Dermatol 2006; 7(2):107–120.CrossRefGoogle Scholar
Bouelle, K. Management of complications after implantation of fillers. J Cosmet Dermatol 2004; 3(1):2–15.CrossRefGoogle Scholar
McCraken, MS, Khan, JA, Wulc, AE, et al. Hyaluronic acid gel (Restylane) filler for facial rhytides: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. Ophthal Plast Reconstr Surg 2006; 22:188–191.CrossRefGoogle Scholar
Duffy, DM. Complications of fillers: overview. Dermatol Surg 2005; 31:1626–1633.CrossRefGoogle ScholarPubMed
Ciocon, JO, Ciocon, DG, Galindo, DJ. Dietary supplements in primary care. Geriatrics 2004; 59(9): 20–24.Google ScholarPubMed
Gladstone, HB, Cohen, JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg 2007; 6:34–39.CrossRefGoogle Scholar
Seeley, BM, Denton, AB, Ahn, MS, Maas, CS. Effect of homeopathic Arnica montana on bruising in face-lifts. Arch Facial Plast Surg 2006; 8:54S–59S.CrossRefGoogle ScholarPubMed
Totonchi, A, Guyuron, B. A randomized, controlled comparison between Arnica and steroids in the management of postrhinoplasty ecchymosis and edema. Plast Reconstr Surg 2007; 120:271–274.CrossRefGoogle ScholarPubMed
Smethurst, PA, Onley, DJ, Jarvis, GE, et al. Structural basis for the platelet-collagen interaction: the smallest motif within collagen that recognizes and activates platelet glycoprotein VI contains two glycine–proline–hydroxyproline triplets. J Biol Chem 2007; 282(2): 1296–1304.CrossRefGoogle ScholarPubMed
Baumann, L. Dermal fillers. J Cosmet Dermatol 2004; 3:249–250.CrossRefGoogle ScholarPubMed
Narins, RS, Brandt, F, Leyden, J, et al. A randomized, double-blind multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29:588–595.Google ScholarPubMed
Berlin, A, Cohen, JL, Goldberg, DJ. Calcium hydroxyapatite for facial rejuvenation. Semin Cutan Med Surg 2006; 25:132–137.CrossRefGoogle ScholarPubMed
Roy, D, Sadick, N, Mangat, D. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxyapatite microspheres. Dermatol Surg 2006; 32:1134–1139.Google Scholar
Vleggaar, D. Soft tissue augmentation and the role of poly-L-lactic acid. Plast Recontr Surg 2006; 118: 46S–54S.CrossRefGoogle ScholarPubMed
Hanke, CW, Higley, HR, Jolivette, DM, Swanson, NA, Stegman, SJ. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 1991; 25:319–326.CrossRefGoogle ScholarPubMed
Schanz, S, Schippert, W, Ulmer, A, Rassner, G, Fierlbeck, G. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002; 146:928–929.CrossRefGoogle Scholar
Baumann, LS, Daza, I, Lourenco, AC, Lazarus, M. Cosmetic dermatology. In Marks, R, Leyden, JL, eds. Dermatologic Therapy in Current Practice, 1st edn. Elsevier Saunders: Philadelphia, 2001; 237.Google Scholar
Castillo, GD. Management of blindness in the practice of cosmetic surgery. Otolaryngol Head Neck Surg 1989 Jun 100(6):559–562.CrossRefGoogle ScholarPubMed
Glaich, AS, Cohen, JL, Goldberg, LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006; 32(2):285–290.Google ScholarPubMed
Schanz, S, Schippert, W, Ulmer, A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane®). Br J Dermatol 2002; 146:928–929.CrossRefGoogle Scholar
Brody, HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31(8):893–897.CrossRefGoogle ScholarPubMed
Hirsch, RJ, Lupo, M, Cohen, JL, Duffy, D. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol 2007; 6(3):325–328.Google ScholarPubMed
Hirsch, RJ, Cohen, JL, Carruthers, JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg 2007; 33(3):357–360.Google Scholar
Hirsch, RJ, Narurkar, V, Carruthers, J. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med 2006; 38:202–204.CrossRefGoogle ScholarPubMed
Suhai, B, Horvath, G. How well does the Rayleigh model describe the E-vector distribution of skylight in clear and cloudy conditions? A full-sky polarimetric study. J Opt Soc Am A Opt Image Sci Vis 2004; 21(9): 1669–1676.CrossRefGoogle ScholarPubMed
Anderson, RR. Rest azured?J Am Acad Dermatol 2001; 44(5):874–875.CrossRefGoogle ScholarPubMed
Hirsch, RJ, Narurkar, V, Carruthers, JD. Management of hyaluronic acid induced Tyndall effects. Lasers Surg Med 2006; 38(3):202–204.CrossRefGoogle ScholarPubMed
Hirsch, RJ, Brody, HJ, Carruthers, JD. Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid. J Cosmet Laser Ther 2007; 9(3):182–185.CrossRefGoogle ScholarPubMed
Klein, AW. Skin filling. Collagen and other injectables of the skin. Dermatol Clin 2001; 19:491–508.CrossRefGoogle Scholar
Matarrasso, SL. The use of injectable collagens for aesthetic rejuvenation. Semin Cutan Med Surg 2006; 25(3):151–157.CrossRefGoogle Scholar
Friedman, PM, Mafong, EA, Kauvar, ANB, Geronemus, RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002; 28:491–494.Google ScholarPubMed
Eberhart, AH, Weiler, CR, Erie, JC. Angioedema related to the use of hyaluronidase in cataract surgery. Am J Ophthalmol 2004; 138:142–143.CrossRefGoogle ScholarPubMed
Agrawal, A, McLure, HA, Dabbs, TR. Allergic reaction to hyaluronidase after a peribulbar injection. Anesthesia 2003; 58:493–494.CrossRefGoogle ScholarPubMed
Ahluwalia, HS, Lukaris, A, Lane, CM. Delayed allergic reaction to hyaluronidase: a rare sequel to cataract surgery. Eye 2003; 17(2):263–266.CrossRefGoogle ScholarPubMed
Nicolau, PJ. Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstr Surg 2007; 119:2271–2286.CrossRefGoogle ScholarPubMed
Alcalay, J, Alkalay, R, Gat, A, Yorav, S. Late-onset granulomatous reaction to Artecoll. Dermatol Surg 2003; 29(8):859–862.Google ScholarPubMed
Lemperle, G, Rullan, PP, Gauthier-Hazan, N. Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006; 118:92S–107S.CrossRefGoogle ScholarPubMed
Senet, P, Bachelez, H, Ollivaud, L, Vignon-Pennamen, D, Dubertret, L. Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol 1999; 140(5):985–987.CrossRefGoogle ScholarPubMed
Blugerman, G, Schacelzon, D, Dreszman, R. Intralesional use of 5-FU in subcutaneous fibrosis. J Drugs Dermatol 2003; 2:169–171.Google ScholarPubMed
Cited by

Send book to Kindle

To send this book to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats

Send book to Dropbox

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Dropbox.

Available formats

Send book to Google Drive

To send content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about sending content to Google Drive.

Available formats